Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,472.00
Bid: 12,492.00
Ask: 12,496.00
Change: 74.00 (0.60%)
Spread: 4.00 (0.032%)
Open: 12,432.00
High: 12,526.00
Low: 12,318.00
Prev. Close: 12,398.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK PM: Covid passports may not be possible until full vaccine rollout

Thu, 25th Mar 2021 15:03

(Alliance News) - UK Prime Minister Boris Johnson has said it may not be feasible to implement coronavirus health certificates until everyone has been offered a vaccine, as publicans criticised his plans.

The prime minister said on Thursday that the government will say more on their possible use in early April, and suggested they could also be based on whether individuals have developed antibodies through infection, as well as vaccinations and negative tests.

But landlords rejected their use after his earlier suggestion it could be up to them to decide whether to screen customers' certificates on entry, ahead of fresh details emerging of a possible incentive for pubs to adopt the measure.

Johnson also defended his credentials as a "freedom lover" as some lockdown-sceptic Conservative backbenchers prepared to rebel in a Commons vote to extend coronavirus laws for a further six months.

The boss of the Shepherd Neame chain said that making jabs mandatory for entry to pubs is a "fairly poorly thought-out idea", as trade bodies suggested the idea was "simply unworkable".

Johnson insisted "no decisions have been taken at all", saying that there will be an update on the review into their possible use on either April 5 or 12, and said that "whatever happens" the April 12 reopening of pub gardens will be unaffected.

The prime minister said that "I do think there is going to be a role for certification", though it is possible this will be limited to foreign travel.

"There are three basic components. There's the vaccine, there's your immunity you might have had after you've had Covid and there's testing – they are three things that could work together," Johnson told broadcasters during a visit to the Monkey Puzzle Day Nursery in Greenford.

But he acknowledged there are "moral complexities" and "ethical problems" that must be addressed, raising concerns that pregnant women and those with medical reasons cannot be vaccinated.

"You might only be able to implement a thoroughgoing vaccination passport scheme, even if you wanted such a thing, in the context of when absolutely everybody had been offered a vaccine," Johnson added.

Ministers have insisted that their target of offering all adults a vaccine by the end of July will be met despite the EU's threat to control supplies from the continent.

EU leaders will discuss proposals aimed at tightening restrictions on vaccine exports at a virtual European Council summit on Thursday.

Meanwhile, MPs will be asked to approve the regulations for the route out of lockdown and keep some of the emergency powers in the Coronavirus Act in place until September.

Though they are expected to pass comfortably because Labour will not oppose them, the leader of the Covid Recovery Group of lockdown-sceptic Tory MPs was highly critical of the move.

Mark Harper, a former chief whip, said he has not "heard a single good answer about why" the government wants to extend "very significant draconian powers" for a further six months.

Ahead of the vote, Johnson said: "The libertarian in me is also trying to protect people's fundamental right to life and their ability to live their lives normally.

"And the only way really to restore that for everybody is for us to beat the disease and the best path to freedom is down the cautious but irreversible road map that we've set out – that's what the freedom lover wants."

On Wednesday, the prime minister said it "may be up to individual publicans" whether they carry out health certificate checks on punters.

Jonathan Neame, the chief executive of Shepherd Neame pub group, ruled out making vaccines mandatory for entry to his premises, warning bar staff could be "subject to intimidation".

"This is fraught with difficulty, I think, and it is, in my view, a fairly poorly thought out idea at this stage," he told BBC Radio 4's Today programme.

Kate Nicholls, the chief executive of the UKHospitality trade body, said the plan is "simply unworkable" and the British Beer and Pub Association said the requirement would not be "appropriate or necessary".

Cabinet Office minister Michael Gove is reviewing the possible use of coronavirus status certificates under plans to ease England's lockdown.

The use of certificates may not be as straightforward as vaccine or no vaccine, as recent negative test status may also be considered.

A Whitehall source told the PA news agency that landlords may be able to scrap social distancing if they check Covid health certificates on entry, in a move that would allow them to operate at much higher capacity.

Under the suggestion being considered in the review, those who do not want to enforce the checks would be allowed to reopen but would have to ensure social distancing is maintained.

Johnson insisted "blockades" are not the way forward as EU leaders were holding a virtual meeting to discuss tightening vaccine export restrictions, as the bloc is embroiled in an enduring row over supply with AstraZeneca PLC.

A joint statement moving to cool tensions said the two sides were seeking a "win-win" deal to increase supplies across the UK and EU.

Government data up to Tuesday showed 28.7 million people have received a first vaccine dose, a rise of 325,650 on the previous day.

A further 98 people had died within 28 days of testing positive for Covid-19 as of Wednesday, bringing the total by that measure to 126,382.

As of 9am on Wednesday, there had been a further 5,605 lab-confirmed cases in the UK, bringing the total to 4.3 million.

By Sam Blewett

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
20 Jun 2024 10:56

TOP NEWS: AstraZeneca's Truqap gets OK from EU for breast cancer form

(Alliance News) - AstraZeneca PLC on Thursday said that the EU approved its prescription medicine Truqap, in combination with hormonal therapy Faslodex, for the treatment of a form of breast cancer.

Read more
18 Jun 2024 09:33

TOP NEWS: AstraZeneca disappointed by breast cancer drug trial results

(Alliance News) - AstraZeneca PLC on Tuesday said findings from a breast cancer drug trial showed that Truqap did not meet its primary endpoints.

Read more
18 Jun 2024 07:51

LONDON BRIEFING: Ashtead profit declines; Whitbread sales rise

(Alliance News) - London's FTSE 100 is called to open higher on Tuesday, taking confidence from a decent showing for US equities overnight, with inflation data and central bank decisions the key plot points as the week progresses.

Read more
18 Jun 2024 07:17

AstraZeneca trial fails to treat 'challenging' breast cancer

(Sharecast News) - AstraZeneca announced on Tuesday that the phase three 'CAPItello-290' trial for 'Truqap', or capivasertib, in combination with paclitaxel did not achieve its primary endpoints.

Read more
17 Jun 2024 09:09

TOP NEWS: Astra's Imfinzi plus chemo approved for cancer form in US

(Alliance News) - AstraZeneca PLC on Monday said it secured a new US approval for cancer treatment Imfinzi, also known as durvalumab, hailing an "important new option" for patients.

Read more
17 Jun 2024 07:48

LONDON BRIEFING: Astra gets US drug approval; Ascential trades in line

(Alliance News) - London's FTSE 100 is called to open solidly higher on Monday, recovering some poise after a tricky week, with eyes turning to the Bank of England.

Read more
17 Jun 2024 07:23

IN BRIEF: AstraZeneca gets positive cancer test results for Calquence

AstraZeneca PLC - Cambridge, England-based pharmaceutical maker - Reports promising test results for one of its cancer therapies. The Echo phase III trial shows that Calquence, when used in combination with bendamustine and rituximab, demonstrates a clinically meaningful improvement in progression-free survival in patients with untreated mantle cell lymphoma. Compared to standard-of-care chemoimmunotherapy, the combination with Calquence, whose generic name is acalabrutinib, shows a 27% reduced risk of disease progression or death. Mantle cell lymphoma is rare and typically aggressive form of non-Hodgkin lymphoma, Astra explains.

Read more
17 Jun 2024 07:15

AstraZeneca's Imfinzi gets US approval for endometrial cancer patients

(Sharecast News) - AstraZeneca said its Imfinzi cancer treatment had been approved in the US as treatment for adult patients with primary advanced or recurrent endometrial cancer.

Read more
12 Jun 2024 20:56

AstraZeneca's Farxiga approved to treat paediatric type-2 diabetes

(Alliance News) - AstraZeneca PLC on Wednesday said its Farxiga treatment has been approved in the US to treat some diabetes sufferers.

Read more
10 Jun 2024 09:10

LONDON BROKER RATINGS: JPMorgan cuts Aviva but lifts M&G

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday:

Read more
10 Jun 2024 08:30

TOP NEWS: Astra's Tagrisso gets US priority review for lung cancer

(Alliance News) - AstraZeneca PLC on Monday celebrated a breakthrough therapy designation for its cancer drug Tagrisso, aimed at treating a form of non-small cell lung cancer.

Read more
10 Jun 2024 07:37

LONDON BRIEFING: FTSE called down amid political uncertainty in EU

(Alliance News) - Stocks in London are called to open lower on Monday, setting off the week on the backfoot, with eyes on the US Federal Reserve's latest interest rate decision.

Read more
10 Jun 2024 06:25

London pre-open: Stocks set for lower start after EU elections

(Sharecast News) - Stocks in London look primed for a lower start as investors digest the gains made by far right parties in Austria, Germany, but above all France, at the European Union elections that were held at the weekend.

Read more
5 Jun 2024 09:52

LONDON BROKER RATINGS: Berenberg raises Taylor Wimpey to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Read more
5 Jun 2024 09:27

AstraZeneca completes USD2.4 billion Fusion Pharmaceuticals purchase

(Alliance News) - AstraZeneca PLC on Wednesday said it successfully completed the acquisition of Boston, Massachusetts-based Fusion Pharmaceuticals Inc.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.